|
389 A phase 1, dose-escalation, first-in-human study of ARQ 087, an oral pan-FGFR inhibitor, in adult subjects with advanced solid tumors |
|
|
|
Title: |
389 A phase 1, dose-escalation, first-in-human study of ARQ 087, an oral pan-FGFR inhibitor, in adult subjects with advanced solid tumors |
Author: |
Papadopoulos, K. Tolcher, A. Kittaneh, M. Patniak, A. Rasco, D. Chambers, G. Newth, G. Savage, R. Hall, T. Schwartz, B. Kazakin, J. LoRusso, P. |
Appeared in: |
European journal of cancer |
Paging: |
Volume 50 (2014) nr. S6 pages 1 p. |
Year: |
2014 |
Contents: |
|
Publisher: |
European Association for Cancer Research |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|